Studies and Surveys

06/28/2011 - 4:49pm

SymphonyIRI: Gas prices limit trips to stores

Looming gas prices are taking a toll on consumers' shopping habits, according to a special report by SymphonyIRI Group.

06/28/2011 - 4:34pm

Survey shows Americans want to see natural, organic claims on food product labels

It seems that some Americans look for such claims as "natural," "organic" and "grown in the USA" on food labels.

06/28/2011 - 2:02pm

Study: Tradjenta reduces blood sugar, weight among patients

New data from a late-stage clinical trial of a recently approved drug for Type 2 diabetes show improved blood-sugar control in adults who take it with metformin or alone.

06/28/2011 - 10:59am

Lyxumia demonstrates noninferiority to Byetta in late-stage trial

An investigational Sanofi drug for diabetes works at least as well as a similar treatment already on the market, and results in less abnormally low blood sugar, according to late-stage clinical trial results presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego this past weekend.

06/28/2011 - 10:42am

Sanofi presents study data at American Diabetes Association’s 71st Scientific Sessions

A new study indicated that two insulin products made by French drug maker Sanofi lower blood-glucose levels to a greater extent than premixed insulin, and with improvements in quality of life and less hypoglycemia.

06/28/2011 - 9:03am

AstraZeneca, BMS say late-stage trial of Onglyza met primary endpoint

A cobranded Type 2 diabetes treatment may help reduce blood-sugar levels among patients when combined with insulin (with or without metformin), according to a late-stage clinical trial.

06/27/2011 - 3:54pm

Report: Some branded diabetes drug prices at Walmart, Kmart rise at fast rate

Prices for the top 10 most prescribed branded diabetes drugs have risen faster at Walmart and Kmart than at other retailers, according to a published report.

06/27/2011 - 1:05pm

Novo Nordisk's Victoza helps patients achieve blood-sugar control when switching from exenatide or sitagliptin

Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

06/27/2011 - 12:07pm

Study: Insulin lispro premixed insulin analogs may be more cost-effective Type 2 diabetes treatment

An insulin product made by Eli Lilly appears likely to be more cost-effective than long-acting insulin analog, according to a study presented Friday at the American Diabetes Association’s 71st Scientific Sessions in San Diego.

06/27/2011 - 10:46am

Adding Byetta to diabetes regimen could cut heart failure risk

Use of a drug for Type 2 diabetes made by Eli Lilly and Amylin Pharmaceuticals may lower patients’ risk of heart failure, according to a new study.